Recombinant Human PRKAB2 Protein，His

PRKAB2, or Protein Kinase AMP-Activated Non-Catalytic Subunit Beta 2, is a vital component of the AMP-activated protein kinase (AMPK) complex, which plays a crucial role in cellular energy homeostasis. The increasing prevalence of metabolic disorders, such as obesity and type 2 diabetes, has led to heightened interest in understanding the regulatory mechanisms of AMPK, as it helps monitor and respond to cellular energy levels. Research has indicated that PRKAB2, as a non-catalytic subunit, is involved in modulating AMPK activity in response to environmental stressors, thus impacting various physiological processes, including glucose uptake, lipid metabolism, and cell growth. Additionally, mutations or dysregulation in PRKAB2 have been associated with metabolic dysfunctions, making it a potential therapeutic target. Studies involving PRKAB2 recombinant proteins can provide insights into its structural and functional characteristics, elucidating its role in AMPK signaling pathways. The exploration of PRKAB2 not only enhances our understanding of energy regulation in cells but also opens avenues for developing novel strategies for treating metabolic diseases. This research emphasizes the significance of PRKAB2 in maintaining metabolic balance and its potential implications in therapeutic interventions for metabolic disorders, highlighting the relevance of recombinant protein studies in advancing our knowledge in this field.